Bionano Genomics (BNGO) Short Interest Ratio & Short Volume $3.00 -0.05 (-1.64%) Closing price 08/6/2025 04:00 PM EasternExtended Trading$3.06 +0.06 (+1.97%) As of 08/6/2025 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Bionano Genomics Short Interest DataBionano Genomics (BNGO) has a short interest of 412,500 shares, representing 12.31% of the float (the number of shares available for trading by the public). This marks a -17.19% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.1, indicating that it would take 4.1 days of the average trading volume of 103,785 shares to cover all short positions.Current Short Interest412,500 sharesPrevious Short Interest498,100 sharesChange Vs. Previous Month-17.19%Dollar Volume Sold Short$1.39 millionShort Interest Ratio4.1 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares3,360,000 sharesFloat Size3,350,000 sharesShort Percent of Float12.31%Today's Trading Volume44,747 sharesAverage Trading Volume103,785 sharesToday's Volume Vs. Average43% Short Selling Bionano Genomics? Sign up to receive the latest short interest report for Bionano Genomics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBNGO Short Interest Over TimeBNGO Days to Cover Over TimeBNGO Percentage of Float Shorted Over Time Bionano Genomics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2025412,500 shares $1.39 million -17.2%12.3%4.1 $3.38 6/30/2025498,100 shares $1.63 million -9.3%14.9%3.7 $3.28 6/15/2025549,000 shares $2.00 million -10.2%16.4%4 $3.65 5/31/2025611,100 shares $2.24 million +6.4%18.2%4.5 $3.67 5/15/2025574,300 shares $2.26 million +18.1%17.1%3.9 $3.93 4/30/2025486,200 shares $1.94 million -18.6%15.7%3.5 $3.99 4/15/2025597,400 shares $2.67 million +1.6%19.3%3.1 $4.47 3/31/2025587,800 shares $1.64 million +15.7%19.6%3.3 $2.79 3/15/2025508,200 shares $1.76 million +0.3%18.7%2.4 $3.47 2/28/2025506,700 shares $2.11 million +7.6%18.6%2.4 $4.16 Get the Latest News and Ratings for BNGO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bionano Genomics and its competitors with MarketBeat's FREE daily newsletter. 2/15/2025471,100 shares $2.71 million +6.1%17.3%2.3 $5.76 1/31/2025443,900 shares $2.30 million +30.0%19.1%2.4 $5.19 1/15/2025341,500 shares $4.07 million -98.1%14.7%2.4 $11.92 12/31/202417,650,000 shares $5.09 million +11.4%12.7%2.6 $0.29 12/15/202415,840,000 shares $3.80 million +25.1%15.6%5.5 $0.24 11/30/202412,660,000 shares $3.29 million +4.5%12.5%4.8 $0.26 11/15/202412,110,000 shares $2.98 million +23.2%12.0%5.2 $0.25 10/31/20249,830,000 shares $2.85 million +28.2%10.3%4.9 $0.29 10/15/20247,670,000 shares $2.53 million +26.4%9.0%4.2 $0.33 9/30/20246,070,000 shares $2.76 million +45.9%8.8%3.9 $0.45 9/15/20244,160,000 shares $1.79 million +13.0%6.1%2.4 $0.43 8/31/20243,680,000 shares $1.80 million -13.0%5.4%2.1 $0.49 8/15/20244,230,000 shares $2.19 million -5.4%6.2%2.4 $0.52 7/31/20244,470,000 shares $2.87 million -7.1%6.5%2.7 $0.64 7/15/20244,810,000 shares $3.02 million -16.6%7.0%3.4 $0.63 6/30/20245,770,000 shares $3.91 million +9.9%8.4%4.1 $0.68 6/15/20245,250,000 shares $4.36 million +11.9%7.7%4 $0.83 5/31/20244,690,000 shares $4.54 million -5.8%6.9%3.6 $0.97 5/15/20244,980,000 shares $5.73 million -3.3%7.5%3.6 $1.15 4/30/20245,150,000 shares $4.55 million -3.9%7.8%3.6 $0.88 4/15/20245,360,000 shares $4.66 million +1.7%8.9%3.5 $0.87 3/31/20245,270,000 shares $5.85 million -3.7%9.8%3.2 $1.11 3/15/20245,470,000 shares $5.52 million +4.6%10.2%3.1 $1.01 2/29/20245,230,000 shares $6.54 million -7.1%9.7%2.8 $1.25 2/15/20245,630,000 shares $7.15 million +0.5%14.8%3.1 $1.27 1/31/20245,600,000 shares $6.61 million +14.5%14.7%3.1 $1.18 1/15/20244,890,000 shares $6.65 million -3.4%12.8%2.9 $1.36 12/31/20235,060,000 shares $9.56 million -1.6%13.3%3.4 $1.89 12/15/20235,140,000 shares $7.71 million -7.2%13.5%4.1 $1.50 11/30/20235,540,000 shares $8.81 million -21.8%14.5%5.6 $1.59One stock to replace Nvidia (Ad)Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.Click to get the full details on Eric Fry's "Nvidia alternative" right here. 11/15/20237,080,000 shares $9.70 million +7.1%18.6%7.8 $1.37 10/31/20236,610,000 shares $9.12 million +15.6%19.1%7.6 $1.38 10/15/20235,720,000 shares $12.70 million +13.0%16.6%6.3 $2.22 9/30/20235,060,000 shares $15.33 million -0.8%16.9%5.8 $3.03 9/15/20235,100,000 shares $16.58 million +6.9%17.0%5 $3.25 8/31/20234,770,000 shares $18.41 million +15.2%15.7%4.3 $3.86 8/15/20234,140,000 shares $13.83 million -8.4%13.6%3.7 $3.34 7/31/20234,520,000 shares $26.56 million -89.7%N/A4.2 $5.88 7/15/202343,910,000 shares $28.45 million -8.8%N/A4.4 $0.65 6/30/202348,120,000 shares $29.35 million -19.5%N/A4.6 $0.61 6/15/202359,800,000 shares $44.22 million -4.5%N/A6.5 $0.74 5/31/202362,620,000 shares $43.33 million -2.8%N/A7.7 $0.69 5/15/202364,400,000 shares $42.67 million +3.4%N/A8.7 $0.66 4/30/202362,260,000 shares $42.83 million -1.0%N/A8.7 $0.69 4/15/202362,890,000 shares $68.55 million +8.0%N/A8.8 $1.09 3/31/202358,260,000 shares $64.67 million +6.4%N/A9.5 $1.11 3/15/202354,780,000 shares $65.74 million -5.0%N/A8.5 $1.20 2/28/202357,650,000 shares $77.25 million +17.2%N/A8.1 $1.34 2/15/202349,200,000 shares $80.20 million -5.9%N/A6.9 $1.63 1/31/202352,260,000 shares $94.59 million -1.8%N/A7.1 $1.81 1/15/202353,220,000 shares $96.33 million +2.8%N/A6.9 $1.81 12/30/202251,790,000 shares $75.61 million +6.2%N/A7 $1.46 12/15/202248,760,000 shares $94.11 million +15.6%N/A6.5 $1.93 11/30/202242,200,000 shares $84.82 million -1.3%N/A6.1 $2.01 11/15/202242,740,000 shares $120.10 million -6.6%N/A6.5 $2.81 10/31/202245,770,000 shares $107.10 million -2.1%N/A5.5 $2.34 10/15/202246,730,000 shares $95.80 million +8.4%N/A5.7 $2.05 9/30/202243,100,000 shares $78.87 million +5.2%N/A5.4 $1.83 9/15/202240,990,000 shares $96.33 million +8.4%N/A5.1 $2.35 8/31/202237,830,000 shares $93.82 million -3.4%N/A4.7 $2.48 8/15/202239,140,000 shares $140.90 million -14.2%N/A4.8 $3.60 7/31/202245,640,000 shares $84.89 million +3.3%N/A7.2 $1.86 7/15/202244,170,000 shares $68.02 million -0.3%N/A7.1 $1.54 6/30/202244,300,000 shares $61.13 million +16.4%N/A7 $1.38 6/15/202238,050,000 shares $54.41 million -1.7%N/A5.8 $1.43 5/31/202238,710,000 shares $66.97 million -3.1%N/A5.7 $1.73 5/15/202239,930,000 shares $64.69 million -11.7%N/A5.5 $1.62 4/30/202245,210,000 shares $73.69 million +2.4%N/A6.2 $1.63 4/15/202244,170,000 shares $91.43 million +13.9%N/A5.7 $2.07 3/31/202238,790,000 shares $100.08 million +1.0%N/A4.8 $2.58 3/15/202238,390,000 shares $67.18 million -0.5%N/A4.6 $1.75 2/28/202238,580,000 shares $82.56 million +0.6%N/A4.6 $2.14 2/15/202238,370,000 shares $83.65 million +1.8%N/A4.5 $2.18 1/31/202237,680,000 shares $83.65 million +0.2%N/A4.3 $2.22 1/15/202237,600,000 shares $95.88 million -7.2%N/A4.1 $2.55 12/31/202140,520,000 shares $121.15 million -2.3%N/A4.7 $2.99 12/15/202141,480,000 shares $141.86 million +3.3%N/A5 $3.42 11/30/202140,170,000 shares $157.06 million +7.1%N/A4.7 $3.91 11/15/202137,500,000 shares $187.50 million -1.4%N/A4.5 $5.00 10/29/202138,020,000 shares $193.14 million -9.5%N/A4.7 $5.08Man Who Called Nvidia at $1.10 Says Buy This Now... (Ad)In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.Watch Alex's "Next Magnificent Seven" presentation now. 10/15/202142,030,000 shares $216.87 million +4.2%15.1%5.5 $5.16 9/30/202140,330,000 shares $221.82 million -9.4%14.5%4.9 $5.50 9/15/202144,490,000 shares $234.91 million -2.0%16.0%4.5 $5.28 8/31/202145,390,000 shares $264.62 million No Change16.3%4.2 $5.83 8/13/202145,390,000 shares $258.27 million +8.6%16.3%3.1 $5.69 7/30/202141,810,000 shares $247.93 million -6.9%15.0%2.3 $5.93 7/15/202144,920,000 shares $262.33 million -13.8%16.2%2.2 $5.84 6/30/202152,100,000 shares $381.89 million +36.2%18.8%2.2 $7.33 6/15/202138,260,000 shares $281.98 million -0.7%13.8%1.6 $7.37 5/28/202138,520,000 shares $237.67 million +5.4%13.9%1.6 $6.17 5/14/202136,550,000 shares $161.19 million +15.9%N/A1.4 $4.41 4/30/202131,530,000 shares $208.41 million +8.7%N/A1.1 $6.61 4/15/202129,020,000 shares $186.45 million +1.5%N/A0.8 $6.43 3/31/202128,580,000 shares $220.64 million +20.2%N/A0.6 $7.72 3/15/202123,780,000 shares $223.06 million +8.5%N/A0.3 $9.38 2/26/202121,920,000 shares $219.64 million +15.1%N/A0.3 $10.02 2/12/202119,050,000 shares $222.89 million -28.7%N/A0.2 $11.70 1/29/202126,700,000 shares $281.15 million +4.8%N/A0.3 $10.53 1/15/202125,470,000 shares $177.02 million +63.1%N/A0.4 $6.95 12/31/202015,620,000 shares $32.80 million +84.2%N/A0.3 $2.10 12/15/20208,480,000 shares $4.24 million +9.6%N/A1.3 $0.50 11/30/20207,740,000 shares $3.78 million +5.5%N/A1.5 $0.49 11/15/20207,340,000 shares $3.81 million +16.7%N/A1.3 $0.52 10/30/20206,290,000 shares $3.24 million +7.9%N/A1 $0.52 10/15/20205,830,000 shares $3.44 million +0.5%N/A0.6 $0.59 9/30/20205,800,000 shares $3.77 million +6.8%N/A0.3 $0.65 9/15/20205,430,000 shares $3.25 million +7.5%N/A0.2 $0.60 8/31/20205,050,000 shares $3.07 million +16.9%N/A0.2 $0.61 8/14/20204,320,000 shares $3.04 million -43.2%N/A0.2 $0.70 BNGO Short Interest - Frequently Asked Questions What is Bionano Genomics' current short interest? Short interest is the volume of Bionano Genomics shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 412,500 shares of BNGO short. 12.31% of Bionano Genomics' shares are currently sold short. Learn More on Bionano Genomics' current short interest. What is a good short interest ratio for Bionano Genomics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BNGO shares currently have a short interest ratio of 4.0. Learn More on Bionano Genomics's short interest ratio. Which institutional investors are shorting Bionano Genomics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bionano Genomics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Bionano Genomics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.31% of Bionano Genomics' floating shares are currently sold short. Is Bionano Genomics' short interest increasing or decreasing? Bionano Genomics saw a decrease in short interest during the month of July. As of July 15th, there was short interest totaling 412,500 shares, a decrease of 17.2% from the previous total of 498,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bionano Genomics' float size? Bionano Genomics currently has issued a total of 3,360,000 shares. Some of Bionano Genomics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bionano Genomics currently has a public float of 3,350,000 shares. How does Bionano Genomics' short interest compare to its competitors? 12.31% of Bionano Genomics' shares are currently sold short. Here is how the short interest of companies in the industry of "measuring and control equipment" compare to Bionano Genomics: Autoscope Technologies Co. (0.02%), ClearSign Technologies Corporation (0.41%), Data I/O Corporation (0.20%), MultiSensor AI Holdings, Inc. (1.73%), Precipio, Inc. (1.19%), Astrotech Corporation (0.11%), Talis Biomedical Co. (0.30%), Schmitt Industries, Inc. (0.00%), Telesis Bio, Inc. (0.02%), ThermoGenesis Holdings, Inc. (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Bionano Genomics stock? Short selling BNGO is an investing strategy that aims to generate trading profit from Bionano Genomics as its price is falling. BNGO shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bionano Genomics? A short squeeze for Bionano Genomics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BNGO, which in turn drives the price of the stock up even further. How often is Bionano Genomics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNGO, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies AATC Short Interest Data CLIR Short Interest Data DAIO Short Interest Data MSAI Short Interest Data PRPO Short Interest Data ASTC Short Interest Data TLIS Short Interest Data SMIT Short Interest Data TBIO Short Interest Data THMO Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BNGO) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionano Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionano Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BNGO Stock Alerts